SIHUAN PHARM 00460Hong Kong Stock Exchange

0.7404.96%( +0.035 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SIHUAN PHARM (00460) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2010-10-28
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
BMG8162K1137
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)3.07B34/112
Net Profit (Last FY)210.72M41/125
ROE (Last FY)3.07%48/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
车冯升医生 Executive Director
郭维城医生 Executive Director
张炯龙医生 Executive Director
陈燕玲 Executive Director
车雨轩 Non-Executive Director
曾华光 Independent Non-Executive Director
朱迅 Independent Non-Executive Director
王冠 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-26.

About this page

This page shows SIHUAN PHARM (00460) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.